Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68629 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68632 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-06-20 | 2023-07-28 | 195789 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2022-11-14 | 2023-02-09 | 174607 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2020-07-16 | 2020-11-07 | 120494 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-02-16 | 2023-06-09 | 184937 |
| FENTORA | 100MCG | TABLET (EFFERVESCENT) | Resolved | 2020-11-19 | 2021-02-05 | 128600 |
| FENTORA | 100MCG | TABLET (EFFERVESCENT) | Actual shortage | 2025-11-06 | 2026-01-15 | 271217 |
| FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2023-04-27 | 2023-06-21 | 190698 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2019-08-22 | 2019-10-04 | 92143 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2024-05-03 | 2024-09-19 | 226942 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2018-03-13 | 2018-07-30 | 42638 |
| FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2019-06-27 | 2019-08-29 | 87668 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2024-05-09 | 2024-05-16 | 227506 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-07-08 | 2021-10-14 | 142198 |
| FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146115 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2025-03-04 | 2025-06-05 | 251941 |
| FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2023-06-19 | 2023-07-05 | 195548 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146125 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-01-28 | 2021-02-05 | 132630 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMOTRIGINE | 150MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258652 |
| TEVA-LAMOTRIGINE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258646 |
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258507 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258510 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256085 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-25 | 2025-04-25 | 255824 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Discontinued | 2020-07-10 | 2020-07-10 | 120009 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258625 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
| TEVA-LISINOPRIL (TYPE P) | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81400 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258694 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258699 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Discontinued | 2019-08-15 | 2019-08-15 | 91648 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |